[06] Session-2: Immuno-Oncology BC -Clinical advances

[1L13] Neoadjuvant therapy with Immuno-Oncology agents

*Giuseppe Curigliano¹ (1. European Institute of Oncology, IRCCS and University of Milano, Milano, Italy)